Find what you were looking for? Share your thoughts with a short survey


The Psychosis Clinical Academic Group (CAG) brings together the largest group of psychosis expert clinicians, researchers, academics and clinical staff in the world.

As part of the South London and Maudsley Quality Centre, our CAG sets the standards for treatment for over 50 teams, 650 staff and for over 7,000 service users across Southwark, Lambeth, Lewisham and Croydon.Psychosis CAG

Read the latest news from our Psychosis CAG.

The services we work with fall under one of three care pathways: early intervention, which provides community and inpatient care for people at high risk of psychosis, and people experiencing a first episode of psychosis; promoting recovery, which provides community care for people with a psychotic disorder who are not in an acute crisis, but require continued treatment; and complex care which provides rehabilitation services, as well as community based placement monitoring and review.


We have a strong record in providing specialised clinical training for our staff. We also host students from a range of undergraduate and postgraduate programmes at King's College London.


Our research activity is organised around psychosis care pathways. This has fostered the development of early intervention, relapse prevention and treatment resistance as academic specialities in their own right. 

Innovations and achievements

  • Read about how our clinical academic collaborations are improving the lives of our patients in Innovation Impact Stories
  • See 70 examples of key achievements from across our partnership in our CAGraphics booklet.
We have a clear ambition to develop the first comprehensive, stage-specific psychosis service in the world, based on our four 'care pathways'
Professor Philip McGuire, Co-Lead for the Psychosis CAG

Psychosis Clinical Academic Group Leaders

Dr Robert Harland, Clinical Director; Consultant Psychiatrist, South London and Maudsley NHS Foundation Trust and King's College London.

Prof James MacCabe, Professor of Epidemiology and Therapeutics, King's College London.